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ObesityThe role and mechanism of signal transducer and activator of transcription 5B (STAT5B) in adipogenesis remain
unclear. In this study, our data showed that Males absent on the ﬁrst (MOF) protein expression was increased
during 3 T3-L1 preadipocytes differentiation accompanied with STAT5B expression increasing. Over-
expression STAT5B enhanced MOF promoter trans-activation in HeLa cells. Mutagenesis assay and ChIP analysis
exhibited that STAT5B was able to bind MOF promoter. Knocking-down STAT5B in 3 T3-L1 preadipocytes led to
decreased expression of MOF, but resulted in increased expression of peroxisome proliferator-activated receptor
γ (PPARγ), CCAAT/enhancer-binding protein α (C/EBPα) and fatty acid-binding protein 4 (Fabp4), which were
important factors or enzymes for adipogenesis.We also found that knocking-downMOF in 3 T3-L1 preadipocytes
resulted in increased expression of PPARγ, C/EBPα and Fabp4, whichwas in the same trend as STAT5B knocking-
down. Over-expressionMOF resulted in reduced promoter trans-activation activity of C/EBPα. These results sug-
gest that STAT5BandMOFwork as negative regulators in adipogenesis, and STAT5Bmodulates preadipocytes dif-
ferentiation partially by regulating MOF expression.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The excess accumulation of fat due to the hyperplasia and hypertro-
phy of adipocytes will lead to obesity [1,2]. Obesity is a major risk factor
for insulin resistance, type 2 diabetes mellitus and cardiovascularinα; ChIP, chromatin immuno-
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. This is an open access article underdisease and thus has become amajor health problem inmodern society
[3].
Growth hormone (GH) is a 22-kDa peptide that is produced by the
pituitary gland and secreted into the circulation. GH plays essential
roles in growth and metabolism. Deregulation of GH secretion has
been implicated in the development of obesity. In obese people, GH
secretion is usually reduced [4,5]. GH deﬁciency in GH knock-out mice
causes aberrant fat accumulation and obesity [6,7].
STAT5B is an important molecule in GH signaling pathway [8]. In
transgenic mice, deletion of the sequence in growth hormone receptor
(GHR) gene for STAT5B activation resulted in obesity [9]. Other studies
show that STAT5B activation induced by growth hormone down-
regulates the expression of PPARγ, Fabp4 also known as aP2 and fatty
acid synthase (Fasn) [10–13], and thus inhibits adipocyte differentia-
tion. Similarly, drugs that activate STAT5B or over-expression of consti-
tutively active STAT5B inhibit adipocyte differentiation [14,15].
However, some other studies indicate that STAT5B activation may be
necessary for adipocyte differentiation [16,17].
MOF, known as hMOF/MYST1/KAT8 in humans, is ﬁrst identiﬁed in
Drosophila, which possesses an acetyltransferase activity [18]. Inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The expression of STAT5B andMOF are different between 3 T3-L1 predipocytes and
adipocytes. (A) 3 T3-L1 preadipocytes and adipocyteswere stainedwithOil-redO to verify
that differentiation had been completed. (B) Comparison of STAT5B andMOF protein level
between preadipocytes and differentiated adipocytes with Western blot. (C) The mRNA
level of MOF between preadipocytes and adipocytes was analyzed with TR-PCR. (n = 3
for each sample, *, p b 0.05).
Table 1
sequences of primers used for DNA molecular cloning and RT-PCR.
Target genes Sequence
For DNA molecular cloning
pGL3-MOF 1640 bp (+) CGGGGTACCTGGCAGGAGCCAGTCAGTCTC
pGL3-MOF900bp (+) CCCGAGCTCTGCTGTGCCGGAAGTGACCG
pGL3-MOF560bp (+) CGGGGTACCACCCRGAGCGAGAGACGC
pGL3-MOF (−) CCCGAGCTCTGCTGTGCCGGAAGTGACCG
pGL3-MOF promoter mutation
(+)
GCACCATGCATGAATTTCAGGCTAGCC
pGL3-MOF promoter mutation
(−)
AGCAGTATCCTGGGGATTACAGTTG
pGL3-C/EBPα2000 bp (+) CCCCGGTACCTCACCTCAAGCACTTATCCCACTTTCTTT
pGL3-C/EBPα1500 bp (+) CGGGGTACCCAGCAGACCTCCCTAACA
pGL3-C/EBPα800 bp (+) CGGGGTACCCTGGAGACGCAATGAAA
pGL3-C/EBPα200 bp (+) CGGGGTACCGTTGCGCCACGATCTCTC
pGL3-C/EBPα (−) CCCCGAGCTCTTCGGGTCGCGAATGGCCAGGCCCGCG
STAT5B (+) CGGGGTACCATGGCTATGTGGATACAGGC
STAT5B (−) CCCAAGCTTTCATGACTGTGCGTGAGGG
MOF-FLAG (+) TGCTCTAGAATGGCGGCATATGGGAGCTACAGCT
GCAGTTG
MOF-FLAG (−) CGGGGTACCTTACTTGTCATCGTCGTCCTTGTAGCC
TTCTT
GGAAAGCTTGACTGTTTGTG
For RT-PCR
18 s (+) CGCGGTTCTATTTTGTTGGT
18 s (−) AGTCGGCATCGTTTATGGTC
C/EBPα (+) GCGGGAACGCAACAACATC
C/EBPα (−) GTCACTGGTCAACTCCAGCAC
PPARγ2 (+) TGGTGACTTTATGGAGCCTAA
PPARγ2 (−) GGCGAACAGCTGAGAGGACTCTG
Fabp4 (+) AAGGTGAAGAGCATCATAACCCT
Fabp4 (−) TCACGCCTTTCATAACACATTCC
MOF (+) ACCGTGGAGATCGGAGAAAC
MOF (−) GCCTGCTAAAGCCCACATAGTGA
STAT5B (+) CACAGTGGATCGAAAGCCAAG
STAT5B (−) AGCTGGGTGGCCTTAATGTTC
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logical activities, including gene transcription regulation [19], chroma-
tin structure maintenances, cell cycle control, DNA damage and repair
[20]. More recently, MOF is suggested to play essential roles in embry-
onic development and tumorigenesis [21,22].
Previous study reports that STAT5B could bind the GAS cassette
(TTCNNNGAA), and thus regulates gene expression [23]. In the promoter
region of MOF gene, we found a GAS cassette-like sequence in the
upstream from −431 bp to −423 bp (TTCAATGAA). We speculated
that STAT5B might play a role in modulation of MOF gene expression.
In this report, we demonstrated that knock-down of STAT5B
reduced MOF expression in 3 T3-L1 preadipocytes. In addition, knock-
down of either STAT5B or MOF led to enhanced adipocyte differentia-
tion. These results indicate that STAT5B plays an inhibitory role in
adipogenesis, and the effect of STAT5B is at least partially mediated by
MOF.
2. Materials and methods
2.1. Cell culture
Human epithelial carcinoma cells (HeLa) were grown in Dulbecco's
modiﬁed Eagle's medium (DMEM, Invitrogen) with 10% fetal bovine
serum (FBS, Hyclone), 100 U/ml penicillin and 100 mg streptomycin
at 37 °C in a humidiﬁed atmosphere (95% air and 5%CO2). For adipogen-
esis, 3 T3-L1 preadipocytes were grown to conﬂuence in DMEM with
10% newborn calf serum (NCS, Gibco), after two days the culture medi-
umwas replacedwith differentiationmedium containing 10% FBS, 1 μM
dexamethasone (Sigma), 0.5 mM 3-isobutyl-1-methylxanthie (IBMX)
(Sigma), and 10 μg/ml insulin (Sigma). Two days later, the medium
was changed to DMEM with 10% FBS, 10 μg/ml insulin for another 2
days. Then the cells were maintained in DMEM with 10% FBS. Oil redO straining was used to observe adipocyte differentiation. Brieﬂy, after
washed with Phosphate Buffered Saline (PBS) and ﬁxed with 4% para-
formaldehyde for 10 min, the cells were then washed twice with PBS,
stained with 60% saturated Oil Red O for 10 min, and washed twice
with 60% isopropanol.
2.2. DNA molecular cloning
The cDNAs of mouse STAT5B andMOF were obtained from C57BL/6
mouse liver mRNA by reverse transcription-PCR and ligated with
pcDNA3.0 vector at KpnI and HindIII sites, the newly-made cDNAs
were sequenced by Sangon Biotech to exclude the mutations. Full-
length MOF promoter DNA fragment (2000 bp) was obtained from the
genomic DNA of C57BL/6 mouse liver by PCR and was ligated with
pGL3-Basic at KpnI and SacI sites; the PCR primers used to amplify
MOF promoter were as follows: 5′CGGGGTACCGAGTTCTGACCTCAAGC
TGC3′ and 5′CCCGAGCTCTGCTGTGCCGGAAGTGACCG3′. The MOF
promoter-derived fragments, including pGL3-1640 bp, pGL3-900 bp
and pGL3-560 bp were ampliﬁed by PCR with high ﬁdelity DNA
polymerase and inserted into the same vector as the full length, and a
sequence substitution mutation (TTCAATGAA to ATGCATGAA,
−431 bp to−428 bp) of pGL3-Full-lengthMOF promoter was generat-
ed by using site directedmutagenesis strategy. The pGL3-basic and pRL-
TK vectors were from Promega. C/EBPα luciferase reporter constructs
was made in the same way as MOF promoter. The primers used are
listed in Table 1.
2.3. Preparation of STAT5B or MOF KD cell lines
Oligos of shRNAs speciﬁcally targeting to mouse STAT5B and MOF
were cloned into lentiviral vector pGLV-3H1. The oligo sequences for
these shRNA are as follows:
STAT5B: 5-AACGTACAACAATGGATTTACTTTCAAGAGAAGTAAATCC
ATTGTTGTACTTTTTC-3
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CATTGTTGTACGTT-3.
MOF: 5-GATCCGCCGAGAAGAATTCTATGTTTCAAGAGAACATAGAAT
TCTTCTCGGCTTTTTTG-3
5-AATTCAAAAAAGCCGAGAAGAATTCTATGTTCTCTTGAAACATAGA
ATTCTTCTCGGCG-3.
To generate stable cell lines, 3 T3-L1 preadipocytes were infected
with lentivirus containing STAT5B or MOF shRNA or scramble shRNA
to be negative control (NC). After 48 h post-infection, the cells were in-
cubated with drug selectionmedium (normal mediumwith puromycin
2 μg/ml) for 2 weeks, clones were selected and ampliﬁed and
characterized.
2.4. Animal study
Six-week old male C57BL/6 mice were purchased from the Beijing
HFK Bioscience CO.LTD. Animal experiments were conducted according
to the Principles of Laboratory Animal Care established by the National
Institutes of Health. All experiments were approved by the Animal
Care and Use Committee at Shandong University. Mice were dividedFig. 2.MOF expression is increased in concert with STAT5B during 3 T3-L1 adipocyte differentia
adipogenesis induction medium as described in Materials and Methods. At different induction
proﬁles during 3 T3-L1 preadipocytes differentiation. The H4K16ac level was also detected du
as internal loading control. (C, D, E, F) Semi-quantitative analyses of Western blotting (n = 3 finto two groups, with one normal feeding group fed with a control
diet containing 5% fat and the other group fed with a high-fat diet con-
taining 20% fat. Animal body weights were measured once a week and
the body weight 30% greater than the normal diet mouse was consid-
ered to be fat. The animals were sacriﬁced following deep anesthesia
with ether. Visceral adipose tissues were collected and snap frozen in
liquid nitrogen.2.5. RNA extraction and real-time quantitative-PCR (RT-PCR) performing
Total RNA was extracted with TRIzol (9109, TaKaRa) according to
manufacturer instructions from 3 T3-L1 preadipocytes and adipocytes,
reverse transcription was carried out according to the manufacturer's
instruction with the ReverTra Ace® qPCR RT kit (FSQ-101, TOYOBO).
RT-PCR was performed by monitoring the increase in ﬂuorescence of
the SYBR green dye (UltraSYBR Mixture CW0956) using the CFX96TM
Real-Time System (Bio-Rad) according to the manufacturer's instruc-
tions. 18 s rRNA was used as an internal control. The primers used are
listed in Table 1.tion. (A) 3 T3-L1 preadipocyteswere induced to differentiate intomature adipocytes in the
days, cells were subjected to Oil-red O staining. (B) STAT5B and MOF protein expression
ring the adipogenesis process. PPARγ was used as a marker for adipogenesis and β-actin
or each sample, *, p b 0.05; **, p b 0.01).
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Transfectionwas performedwith lipofectamine 2000 (Invitrogen) ac-
cording to the manufacturer's instruction. One day before transfection,
2 × 105 cells were seeded in one well of 24-well plate with 500 μl of
growth medium without antibiotics so that cells would be 90–95% con-
ﬂuent at the time of transfection. Cells were co-transfected with 400 ng
luciferase reporter plasmid (pGL3-Full-length MOF promoter or pGL3-
MOFpromoter deletion ormutation) or PGL3-basic (control), 400ngpro-
tein expression plasmid (pcDNA-STAT5B) or 400 ng pcDNA (vector) and
40 ng pRL-TK(a Renilla luciferase plasmid). For each transfection, 2 μl li-
pofectamine 2000 was used. After transfection for 24 h, HeLa cells in
24-well plates were lysed for luciferase assay. Luciferase activities were
determined by luciferase assay kit from Beyotime Biotechnology. Lucifer-
ase activity was normalized to Renilla luciferase activity, which was de-
termined as described previously [24]. Transfections were performed in
triplicate for each independent experiment. The luciferase assay of MOF
on C/EBPα promoter was similar to what described above.
2.7. Western blotting
3 T3-L1 preadipocytes, 3 T3-L1 adipocytes or epididymal fat of normal
feeding and HFD mice were lysed in RIPA buffer (50 mM Tris pH 7.4,
150 mM NaCl, 1% tritonX-100, 1% sodium deoxycholate, 0.1% SDS,Fig. 3. STAT5B andMOF expression are increased in white adipose tissue from HFD fed obes
body weight was measured every week. When body weight of HFD group reached 20% exc
n= 6 (B)Western blot analysis the expression of STAT5B andMOF inmiceWAT (Epididym
p b 0.05; **, p b 0.01).Beyotime Biotechnology), supplemented with protease inhibitor cocktail
(Sigma), and the protein content was measured using the BCA Protein
AssayKit (SangonBiotech).Western blottingwas carried out as previous-
ly described [25], using mouse anti-MOF antibody (1:1000), rabbit anti-
STAT5B antibody (1:1000), from Santa Cruz Biotechnology; rabbit anti-
PPARγ antibody (1:1000), rabbit anti-Fasn antibody(1:1000), rabbit
anti-Fabp4 antibody (1:1000), rabbit anti-H4K16ac antibody (1:1000)
fromAbcam,mouse anti-beta-actin antibody (1:2000) and secondary an-
tibodies conjugated to horseradish peroxidase (1:5000) from ZSGB-BIO.
2.8. Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) was performed with
1.0 × 107 cells essentially as described [26]. A rabbit anti-STAT5B (Santa
Cruz Biotechnology) was used to precipitate STAT5B binding DNA frag-
ment, and PCR primers F: 5′-CCCCAAGCATCCCATAAA-3′ R: 5′CTCCTCCT
GCCTTGGGTT-3′ were exploited to amplify STAT5B binding site.
2.9. Statistical analysis
All data are expressed as themean±SEM. Analysis of differenceswas
performed using the two-tailed Student's t-test or with analysis of vari-
ance (ANOVA) in Graph Pad Prism 5.0. A value of p b 0.05 (*) was consid-
ered statistically signiﬁcant, p b 0.01 (**) was considered very signiﬁcant.e mice. (A) C57BL/6 mice fed with normal diet or high fat diet (HFD) for 13 weeks, the
ess the normal control group, it was regarded that the obesity model was established.
al fat). (C, D) Semi-quantitative analyses ofWestern blotting (n= 6 for each sample, *,
2438 P. Gao et al. / Cellular Signalling 27 (2015) 2434–24433. Results
3.1. STAT5B andMOF expression are different between 3 T3-L1 predipocytes
and adipocytes
We observed that STAT5B and MOF expression were different be-
tween undifferentiated and differentiated 3 T3-L1 cells (Fig. 1A). The
protein level of MOF was elevated in differentiated 3 T3-L1 cellFig. 4. STAT5B regulates genes associatedwith adipogenesis in 3 T3-L1 adipocytes andMOF expr
for ten days, NC and STAT5B KD cells were subjected to Oil-red O staining. (B, C, D, E) mRNA exp
were analyzed with real-time PCR. ThemRNA level was calculated as a ratio to 18 s rRNA. The r
p b 0.01, vs. NC. (F) STAT5B andMOFprotein expression in STAT5B knocking-down preadipocyt
(n = 3 for each sample, *, p b 0.05; **, p b 0.01).accompanied with STAT5B protein level (Fig. 1B). This suggests that
during adipogenesis the expression of STAT5Bwas positively correlated
with the expression of MOF. We also detected H4K16ac and H3K4me3
levels in these different periods of cells. As the main downstream
molecule of MOF, H4K16ac was also increased, moreover, the modiﬁca-
tion of H3K4me3 which coincided with H4K16ac showed the same
pattern (Fig. 1B). ThemRNA level of MOF was elevated in differentiated
3 T3-L1 cells (Fig. 1C).ession is downregulated in STAT5B knocking-downpreadipocytes. (A) After differentiated
ression levels of STAT5B, C/EBPα, PPARγ and Fabp4 in both preadipocytes and adipocytes
esults are described as the mean± SEM of three independent experiments. *, p b 0.05; **,
es were analyzedwithWestern blot. (G, H) Semi-quantitative analyses ofWestern blotting
2439P. Gao et al. / Cellular Signalling 27 (2015) 2434–24433.2. MOF expression are induced during 3 T3-L1 differentiation
To identify the dynamics of MOF during adipogenesis, 3 T3-L1
preadipocytes cells were cultured and induced to differentiation. Cells
were harvested every two days, 3 T3-L1 cells were fully differentiated
after ten days induction (Fig. 2A). The protein level of MOF wasFig. 5. STAT5B binds to MOF promoter and modulates MOF trans-activation. (A) Luciferase
(B) STAT5B expression in samples from A was analyzed withWestern blot. (C) After starving fo
activity of 2000 bpMOF promoterwas activated by GH. (D) Schematic of themutation GAS sequ
in 3 T3-L1 preadipocytes.When the STAT5B binding site inMOF promoter wasmutated, STAT5
ment. (G) ChIP assay showed that GAS region inMOF promoterwas co-precipitatedwith anti-S
sample, *, p b 0.05; **, p b 0.01).gradually elevated in the process of adipogenesis accompanied with
the increase of STAT5B protein level (Fig. 2B). PPARγ was the critical
marker for adipogenesis, whichwas exploited tomonitor the differenti-
ation level of preadipocytes.We also examined H4K16acwhichwas the
main substrate ofMOF activation and found that H4K16ac levelwas also
up-regulated [27].activity of 2000 bp MOF promoter in HeLa cells was signiﬁcantly activated by STAT5B.
r 3 h, HeLa cells were treated with 125 ng/ml GH in starvation medium for 6 h. Luciferase
ence (−431 to−423) inMOFpromoter. (E) GH enhancedMOFpromoter trans-activation
B failed to enhance MOF promoter trans-activation. (F) STAT5B was activated by GH treat-
TAT5B antibody in 3 T3-L1 cells, rabbit IgGwas used to be negative control. (n= 3 for each
2440 P. Gao et al. / Cellular Signalling 27 (2015) 2434–24433.3. STAT5B andMOF protein levels are both increased in white adipose tis-
sue (WAT) of HFD-fed obese mice
To determine whether STAT5B and MOF were up-regulated in vivo
in adipocytes, we fed C57BL/6 mice with normal diet and HFD, After
13weeks feeding, the bodyweights of obesemice increased signiﬁcant-
ly in the HFD group compared with the normal diet group (Fig. 3A). The
animals were sacriﬁced after deep anesthesia with ether.WATwere ex-
tracted from epididymal fat and analyzed with Western blotting. We
found that STAT5B and MOF were both elevated in epididymal fat of
HFD group (Fig. 3B, C, D).3.4. Knock-down of STAT5B in preadipocytes increases the expression of ad-
ipogenesis genes and decreases the expression of MOF
To further conﬁrm the role of STAT5B in preadipocytes and adipo-
cytes, lentivirus expressing STAT5B shRNA or scramble shRNA was
used to infect 3 T3-L1 preadipocytes. After selected with puromycin,
we obtained the cell lines, in which shRNA was stably expressed. We
induced control (NC, stably express scramble shRNA) and STAT5B
knock-down 3 T3-L1 cell to differentiation for ten days (Fig. 4A), and
then detected genes that associated with adipocyte differentiation by
RT-PCR. The results showed that pro-adipogenesis genes such as
PPARγ, C/EBPα and Fabp4 were up-regulated in STAT5B knock-down
adipocytes compared to the NC cells (Fig. 4B, C, D, and E). These data
suggested that the decrease of STAT5B was favorable to theFig. 6.MOF knocking-down effects adipocyte differentiation. (A) After differentiated for ten day
levels of MOF, PPARγ, C/EBPα and Fabp4 in both preadipocytes and adipocytes were evaluated
was calculated as a ratio to 18 s RNA. The results are shown as themean± SEMof three indepen
with adipogenesis inMOF knockdown adipocyteswere detected byWestern blot. (G, H, I, J) Qua
each sample, *, p b 0.05; **, p b 0.01).differentiation of 3 T3-L1 preadipocytes. As expected, MOF expression
declined accompanied with the decrease of STAT5B in STAT5B knock-
down 3 T3-L1 cells (Fig. 4F). Taken together, all these results suggest
that STAT5Bmay act as a negative regulator in adipocyte differentiation
and there may be some connection between STAT5B and MOF during
adipogenesis.3.5. STAT5B binds to MOF promoter and enhances MOF transcription
To determine whether STAT5B had the effect on MOF trans-
activation, we did luciferase assay. As shown in Fig. 5A and B, over-
expression STAT5B increased the luciferase activity of pGL3-MOF2000
reporter. HeLa cells were transfect with pcDNA-STAT5B, pGL3-
MOF2000, then treated with GH; our data showed that GH elevated
MOF promoter trans-activation (Fig. 5C) in HeLa cells. To narrow-
down the STAT5B regulatory element in MOF promoter, we generated
a series truncation MOF reporters (pGL3-1640 bp, pGL3-920 bp, pGL3-
560 bp) and a potential STAT5B binding defective (−431 bp to
−423 bp TTCAATGAA) MOF reporter (pGL3-2000 mutation) as shown
in Fig. 5D, and did luciferase assays with these reporters in 3 T3-L1
preadipocytes cells. Compared with the pGL3-basic, all plasmids except
pGL3-2000 mutation increased MOF promoter activity after treated
with GH for 6 h (Fig. 5E). In fact, medium that contained fetal bovine
serum could activate STAT5B, in Fig. 5F we showed that STAT5B activa-
tion in 3 T3-L1 cells were much higher when treated with GH in medi-
umwith fetal bovine serum. 3 T3-L1 preadipocytes and adipocytes cellss, NC andMOF KD cells were subjected to Oil-red O staining. (B, C, D, E) mRNA expression
by RT-PCR using RNA extracted from NC cells and MOF knockdown cells. The mRNA level
dent experiments. *, p b 0.05; **, p b 0.01, vs. NC. (F) Protein expression of genes associated
ntitative analyses ofWestern blotting, representative result ofWestern blotting. (n=3 for
2441P. Gao et al. / Cellular Signalling 27 (2015) 2434–2443were applied to ChIP assay with a STAT5B speciﬁc antibody.
ImmunoprecipitatedDNAwas used to amplify theDNA fragment cover-
age of STAT5B putative fragment by PCR (Fig. 5G). Our data conﬁrmed
that STAT5B bound to MOF promoter at TTCAATGAA sequence site.3.6. Knock-down of MOF increases the expression of adipogenesis genes
We exploited lentivirus expressingMOF shRNA and infected 3 T3-L1
preadipocytes. After selection, we obtained the MOF knocking-down
cells and control cells. These cells were applied for differentiation (Fig.
6A). RT-PCR results showed the similar tendency in mRNA expression
of PPARγ, C/EBPα or Fabp4 in MOF knocking-down cells compared to
theNC cells during adipogenesis (Fig. 6B, C, D, andE).Western blot anal-
ysis showed that the protein expression of PPARγ, Fabp4, or Fasn was
up-regulated in MOF knocking-down adipocytes (Fig. 6F). The mRNA
expression of PPARγ and Fabp4 was in concert with their protein ex-
pression when MOF was knocked-down. It should be noted that there
was no difference in STAT5B expression between negative control
(NC) and MOF knocking-down preadipocytes, but when induced for
ten days MOF knocking-down cells had a higher level of STAT5B (data
not shown). All these data suggested that MOF knocking-down caused
similar modulation in adipocyte differentiation as STAT5B knocking-Fig. 7.MOF impacts C/EBPα promoter trans-activation. (A) Luciferase activity of 2000 bp C/EBP
expression in samples from HeLa cells were analyzed with Western blot, BPT stands for transfe
pcDNA and pRL-TK; αMT stands for tansfectant with C/EBPα promoter, MOF-FLAG and pRL-T
EBPα800 bp, and pGL3-C/EBPα200 bp) in HeLa cells were analyzed and only pGL3-C/EBPα20
*, p b 0.05; **, p b 0.01). (D) Schematic for STAT5Bmodulates adipocyte differentiation viaMOF.
the expression of C/EBPα and PPARγ.down did, which indicated MOF might play an important role in adipo-
cyte differentiation as a downstream molecule of STAT5B.
3.7. MOF inhibits the transcription activity of C/EBPα promoter
Luciferase assay were exploited to determine the effect of MOF on
promoter transcription activity of C/EBPα or PPARγ. As shown in Fig.
7, over-expression MOF inhibited the activity of C/EBPα promoter in
HeLa cells, while over-expression MOF did not change the promoter
transcription activity of PPARγ (data not shown). We also generated a
series truncation C/EBPα reporter (pGL3-C/EBPα1500bp, pGL3-C/
EBPα800bp, and pGL3-C/EBPα200bp) and found that the inhibited ef-
fect of MOF to C/EBPα promoter was only attenuated in pGL3-C/
EBPα200bp. These results implied that MOF was a negative regulator
for C/EBPα promoter trans-activation and the regulated element
might between−800 bp and−200 bp.
4. Discussion
Stephens ﬁrst demonstrated that protein levels of STAT5A and 5B
were increased during the differentiation of 3 T3-L1 preadipocytes
[28,29]. Deletion of STAT5A, STAT5B or both in mice resulted in signiﬁ-
cantly reduced fat pad size [30]. These ﬁndings suggested that STAT5α promoter in HeLa cells was signiﬁcantly inhibited by over expression of MOF. (B) MOF
ctant with basic, pcDNA and pRL-TK; αPT stands for transfectant with C/EBPα promoter,
K. (C) Luciferase activity of C/EBPα promoter fragments (pGL3-C/EBPα1500 bp, pGL3-C/
0bp trans-activity was not inhibited by over expression of MOF. (n = 3 for each sample,
STAT5B negativelymodulates adipogenesis via regulatingMOF expression andMOF inhibit
2442 P. Gao et al. / Cellular Signalling 27 (2015) 2434–2443proteins may play important roles in adipogenesis. Previous studies
showed that ectopic expression of STAT5A rather than STAT5B induced
fat cell differentiation [31,32]. In the present study, we demonstrated
that STAT5B protein expression was increased during adipocyte
differentiation, which is in agreement with a previous report [28]. Fur-
thermore, knock-down of STAT5B in 3 T3-L1 preadipocytes increased
the expression of PPARγ, C/EBPα and Fabp4, which are markers of
adipocyte differentiation. Our ﬁndings are in consistency with a previ-
ous report showing that STAT5B over-expression down-regulated
PPARγ and C/EBPα [15].
Interestingly, we found that knock-down of STAT5B resulted in
decreased MOF expression. To conﬁrm the link between STAT5B and
MOF, we examined the MOF promoter sequence and found a GAS
cassette in the upstream from−431 bp to−423 bp (TTCAATGAA) as
previously reported [23]. Global histone H4K16 acetylation in most or-
ganisms is due to the KAT8/MOF/MYST protein [33]. There are two
mammalian MOF complexes that regulate transcription activation,
MSL and MSL1v1 which regulate different regions of target genes. It is
important that not only histone but also non-histone can be acetylated
byMOF-MSL 1v1, such as p53-k120 [34]. MOF can be autoacetylated by
itself on K274, but SIRT1 deacetylate MOF and increase the recruitment
of MOF on chromatin then activate gene expression [35]. It seems that
acetylation of transcriptional regulator may down-regulate its ability
for DNA binding.
MOF proteinwas increased during 3 T3-L1 adipocyte differentiation,
and the expression of MOF and STAT5B proteins were much higher in
white adipose tissues of HFD induced obese mice than control mice.
We proposed that STAT5B might regulate MOF expression by binding
to its promoter. Luciferase reporter assay showed that over-expression
of STAT5B enhanced MOF promoter transcription activity, in which
the STAT5B binding sequence was indispensable. Additional experi-
ments in this study demonstrated that knock-down of MOF in 3 T3-L1
preadipocytes resulted in increased expression of PPARγ, Fabp4, Fasn
and C/EBPα. These ﬁndings suggested that STAT5B may modulate adi-
pocyte differentiation partially by regulating MOF expression. To our
knowledge, this is theﬁrst report proposingMOF as a negative regulator
of adipocyte differentiation.
The precise mechanism underlying the action of MOF in adipocyte
differentiation was not clear. A previous study showed that over-
expression of C/EBPα could regulate PPARγ trans-activation with ste-
roid receptor coactivator-3 (SRC-3) in mouse embryonic ﬁbroblasts
(MEF) [36]. Herein, we demonstrated that over-expression of MOF
inhibited C/EBPα promoter trans-activation in HeLa cells.We thus spec-
ulated that MOFmight inhibit PPARγ expression via regulating C/EBPα.
5. Conclusion
In this study,we demonstrated that STAT5B is a negative regulator of
adipocyte differentiation. MOF expression increases in parallel with
STAT5B during adipogenesis. Knocking-down STAT5B expression in
preadipocytes results in decreased expression ofMOF and increased ex-
pression of adipogenesis activators or enzymes. Knocking-down MOF
expression also resulted in increased expression of adipogenesis activa-
tors in preadipocytes. STAT5B over-expression enhancesMOF promoter
trans-activation and STAT5B is associated with MOF promoter in the
STAT5B putative binding area. Over-expression MOF inhibits C/EBPα
promoter trans-activation. We therefore, conclude that STAT5B nega-
tively modulates adipogenesis via regulating MOF expression, which
subsequently inhibits C/EBPα promoter trans-activation. The signiﬁ-
cance of STAT5B/MOF pathway in adipogenesis needs further
investigation.
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